Cortical plasticity as a new endpoint measurement for chronic pain

<p>Abstract</p> <p>Animal models of chronic pain are widely used to investigate basic mechanisms of chronic pain and to evaluate potential novel drugs for treating chronic pain. Among the different criteria used to measure chronic pain, behavioral responses are commonly used as the...

Full description

Bibliographic Details
Main Author: Zhuo Min
Format: Article
Language:English
Published: SAGE Publishing 2011-07-01
Series:Molecular Pain
Online Access:http://www.molecularpain.com/content/7/1/54
id doaj-081a5ca8ed5c41219598f838d1ddb3db
record_format Article
spelling doaj-081a5ca8ed5c41219598f838d1ddb3db2020-11-25T03:11:23ZengSAGE PublishingMolecular Pain1744-80692011-07-01715410.1186/1744-8069-7-54Cortical plasticity as a new endpoint measurement for chronic painZhuo Min<p>Abstract</p> <p>Animal models of chronic pain are widely used to investigate basic mechanisms of chronic pain and to evaluate potential novel drugs for treating chronic pain. Among the different criteria used to measure chronic pain, behavioral responses are commonly used as the end point measurements. However, not all chronic pain conditions can be easily measured by behavioral responses such as the headache, phantom pain and pain related to spinal cord injury. Here I propose that cortical indexes, that indicate neuronal plastic changes in pain-related cortical areas, can be used as endpoint measurements for chronic pain. Such cortical indexes are not only useful for those chronic pain conditions where a suitable animal model is lacking, but also serve as additional screening methods for potential drugs to treat chronic pain in humans. These cortical indexes are activity-dependent immediate early genes, electrophysiological identified plastic changes and biochemical assays of signaling proteins. It can be used to evaluate novel analgesic compounds that may act at peripheral or spinal sites. I hope that these new cortical endpoint measurements will facilitate our search for new, and more effective, pain medicines, and help to reduce false lead drug targets.</p> http://www.molecularpain.com/content/7/1/54
collection DOAJ
language English
format Article
sources DOAJ
author Zhuo Min
spellingShingle Zhuo Min
Cortical plasticity as a new endpoint measurement for chronic pain
Molecular Pain
author_facet Zhuo Min
author_sort Zhuo Min
title Cortical plasticity as a new endpoint measurement for chronic pain
title_short Cortical plasticity as a new endpoint measurement for chronic pain
title_full Cortical plasticity as a new endpoint measurement for chronic pain
title_fullStr Cortical plasticity as a new endpoint measurement for chronic pain
title_full_unstemmed Cortical plasticity as a new endpoint measurement for chronic pain
title_sort cortical plasticity as a new endpoint measurement for chronic pain
publisher SAGE Publishing
series Molecular Pain
issn 1744-8069
publishDate 2011-07-01
description <p>Abstract</p> <p>Animal models of chronic pain are widely used to investigate basic mechanisms of chronic pain and to evaluate potential novel drugs for treating chronic pain. Among the different criteria used to measure chronic pain, behavioral responses are commonly used as the end point measurements. However, not all chronic pain conditions can be easily measured by behavioral responses such as the headache, phantom pain and pain related to spinal cord injury. Here I propose that cortical indexes, that indicate neuronal plastic changes in pain-related cortical areas, can be used as endpoint measurements for chronic pain. Such cortical indexes are not only useful for those chronic pain conditions where a suitable animal model is lacking, but also serve as additional screening methods for potential drugs to treat chronic pain in humans. These cortical indexes are activity-dependent immediate early genes, electrophysiological identified plastic changes and biochemical assays of signaling proteins. It can be used to evaluate novel analgesic compounds that may act at peripheral or spinal sites. I hope that these new cortical endpoint measurements will facilitate our search for new, and more effective, pain medicines, and help to reduce false lead drug targets.</p>
url http://www.molecularpain.com/content/7/1/54
work_keys_str_mv AT zhuomin corticalplasticityasanewendpointmeasurementforchronicpain
_version_ 1724654388417396736